Anti-Mouse INFNAR-1 MAR1-5A3 mAb

Award Notice Posted

Solicitation number
HT9425-24-D-0009
Agency
Awarded
to Leinco Technologies, Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
HT9425-24-D-0009 Federal IDV award
Place of performance
Fenton, Missouri 63026, United States

Notice details come from SAM.gov. Updated .

About this opportunity

This Award Notice announces that Leinco Technologies, Inc. has been awarded a Firm Fixed Price Indefinite Delivery/Indefinite Quantity (IDIQ) contract by the Defense Health Agency to provide Anti-Mouse IFNAR-1 MAR1-5A3 monoclonal antibody in support of research conducted by the United States Army Medical Research Institute of Infectious Diseases (USAMRIID). The contract has an estimated value of $650,000. Leinco Technologies was selected as the sole source provider after market research determined they are the only vendor capable of consistently producing the specific antibody lot validated for in vivo use in USAMRIID's Crimean-Congo Hemorrhagic Fever Virus (CCHFV) mouse models.

Notice text

Leinco Technologies, Inc. recieved a Firm Fixed Price Sole Source IDIQ award for the delivery of Anit-mouse IFNAR-1 MAR1-5A3; PLATINUM Functional grade antibody in support of United States Army Medical Research Institute of Infectious Diseases (USAMRIID). 

Awarded contract HT9425-24-D-0009 to LEINCO TECHNOLOGIES, INC. for 650000.00 on 2024-08-23.

Files

File Type Posted
JA Sole Source __Redacted_8.23.2024.pdf PDF

Notice history

Notice Type Posted
Anti-Mouse INFAR-1 MAR1-5A3 mAb Latest Award Notice
This notice Original Award Notice

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity